𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pyrimethamine/sulfadoxine still a good bet for malaria prevention

Book ID
120847188
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
121 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized safety and tolerability tri
A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children
✍ J.F. Doherty; A.D. Sadiq; L. Bayo; A. Alloueche; P. Olliaro; P. Milligan; L. von πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Science 🌐 English βš– 474 KB

Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunction with well-established anti-malarial drugs such as sulfadoxine-pyrimethamine may reduce the rate of drug resistance. Such a combination has not pr

Sulfadoxine-pyrimethamine for the treatm
Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children
✍ P. Deloron; J. Mayombo; A. Le Cardinal; J. Mezui-Me-Ndong; C. Bruzi-Baert; F. Le πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 431 KB

Chloroquine can no longer be recommended as the first-line treatment for falciparum malaria in several parts of Africa, given the increasing resistance of Plasmodium falcipanrm to this drug. The sulfadoxinepyrimethamine combination (SP) is obviously an alternative candidate, that has already been se